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The leaves of Atropa belladonna (L) are characterized by the presence of the alkaloid atropine, known for the 
antimuscarinic activity. They are used in therapy, mainly in homeopathic preparations. An HPLC method was developed 
and validated to quantify atropine in belladonna leaves. The samples were extracted with methanol, followed by acid-
base extraction with 5% HCl and dichloromethane. Analysis by HPLC was performed on C18 column, in a linear 
gradient system using two mobile phases (water and acetonitrile), both acidified with trifluoroacetic acid. The 
determinations were performed using a reference standard and a diode array detector at 210 nm. The method was 
validated and proved to be specific/selective, comparing the UV profiles and the purity of the atropine peaks in reference 
and sample solutions and analyzing sample solutions with and without addition of standard, which produced an increase 
only of the area of peak of the sample, without changing the area of the adjacent peaks. The linearity (50 - 200 μg/mL) 
was provided by analysis of the analytical curves of atropine, with r2 = 0.9996. LOD and LOQ were 3.75 and 11.4 
µg/ml, respectively. The method was precise, reproducible and accurate, and presented recovery equal to 103.0%. The 
method was considered robust for the analyzed parameters. Four commercial samples were analyzed and the mean levels 
of atropine found ranged from 0.16 - 0.27 %. Thus, the method developed is effective for atropine quantification in A. 
belladona leaves, because meets validation requirements of current legislation, besides presenting itself as a useful tool in 
the control of the quality of this plant material. 
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Introduction 
 
Atropine is a tropane alkaloid that plays an 
important role in therapy because of its inhibitory action 
on acetylcholine. These metabolites are known as 
antimuscarinic or blocking substances of cholinergic 
muscarinic receptors. Although it can be performed by 
synthetic route, obtaining this metabolite is still 
performed from natural sources, mainly from plants of 
the Solanaceae family, such as Atropa Belladonna L., 
which present atropine as the major compound in its 
composition (1-4). 
Scientific studies have been increasingly driven to 
develop analytical methodologies for the quantification 
of chemical markers in plant materials, resulting in 
quality materials that meet the control parameters 
recommended by the legislation due to the importance 
of raw materials of plant origin and plant medicines for 
the pharmaceutical industry. Plant medicines used as 
raw material in the production of herbal medicinal 
products should be subjected to qualitative and 
quantitative analysis of the active ingredients and / or 
chemical markers, when known. The methodologies 
developed and used in official compendia 
(pharmacopoeias) must be validated and all validation 
steps (specificity/selectivity, linearity, limits of 
detection (LOD) and quantification (LOQ), precision, 
precision and robustness) must be proven (5-9). The 
official compendia describe the determination of total 
alkaloids in A. belladonna by titration method (10-12) 
and also by gas chromatography (13), but these methods 
employ large amounts of solvents, mainly in the 
extraction stage and are difficult to reproduce. 
Developing analytical methods that are capable of 
identifying, separating or quantifying analytes in plant 
materials becomes a challenge, given the complexity of 
the matrices of these materials (14-16). Several authors 
describe methods to quantify tropane alkaloids in the 
Solanaceae Family's plant raw materials, with emphasis 
on Datura, Atropa and Hyosciamus species. Among the 
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techniques used, High Performance Liquid 
Chromatography (HPLC) is the most widely developed 
for this purpose (17-24). Buffered mobile systems or 
having only one salt dissolved in their composition 
(K2HPO4, KH2PO4, for example) are best described for 
quantifying tropic type alkaloids (18-23). Ashtiania and 
Sefidkonb (2011) (21) quantified total alkaloids 
(atropine and scopolamine) in A. belladonna leaf 
cultures using these systems. In 2005, Kursinszki and 
colleagues (24) developed a method, without using 
mobile phase systems with buffer solution, to quantify 
these alkaloids in cultivated roots of this species. Thus, 
a quantitative method to determine atropine in this plant 
drug becomes interesting considering the importance of 
guaranteeing the quality of this material for its use in the 
industry. 
 
Experimental 
 
Chemical and Standard 
 
All solvents (HPLC and analytical grade) were 
purchased from Tedia (Fairfield, CA, USA). Chemical 
Standard of atropine (≥ 99%) (Figure 1) was purchased 
from Sigma-Aldrich (São Paulo, Brazil). The other 
analytical grade reagents were purchased from F. Maia 
(Cotia, SP, Brazil) and Vetec (Duque de Caxias, RJ, 
Brazil). 
 
 
 
Figure 1 Chemical structure of atropine. 
 
Plant material and sample preparation 
 
Four samples the A. belladonna leaves were 
commercially available and named Ab-01, Ab-02, Ab-
03 and Ab-04. The sample Ab-01 was used to develop 
and validate the method. Approximately 0.25 g of the 
powdered drug (particle size - 180 μm) was weighed 
accurately in 50 ml erlenmeyer flask and 15 ml of 
methyl alcohol was added. The flask was closed with 
plastic film and taken to the ultrasonic bath for 60 
minutes (25, 26). The crude methanolic extract was 
filtered through filter paper into a 50 mL round bottom 
flask. The Erlenmeyer flask was washed with 2 x 1 mL 
methyl alcohol p.a. The solvent was removed on a 
rotary evaporator without exceeding 40 °C. The dried 
extract of the flask was transferred to a 250 mL 
separatory funnel using 25 mL of 5% hydrochloric acid 
(5% HCl) with ultrasonic aid to facilitate the 
solubilization of the extract in acid medium. The 
aqueous acid phase was extracted with 3 x 20 mL 
dichloromethane using the first 20 mL to clear the 
residue from the 50 mL round bottom flask. The organic 
phases of the washes were discarded. The aqueous 
extract was basified with ammonium hydroxide (25% 
NH4OH) to pH 10. The alkaloids were extracted with 5 
x 20 mL of dichloromethane. The organic phases were 
combined and dried with 15 g of anhydrous sodium 
sulfate. Then it was filtered through filter paper into a 
porcelain crucible, the sodium sulfate from the filter 
paper was washed with 2 ml of dichloromethane. The 
solvent was evaporated to dryness in a water bath, 
without exceeding 40 °C. The dry extract of alkaloids 
was solubilized with methanol into a 5 mL volumetric 
flask and filtered through a 0.45 μm membrane into a 2 
mL vial. 
 
Instrumentation and HPLC Conditions 
 
The atropine analyses were performed using a 
Waters-Alliance 2695 equipped with a photodiode array 
detector (PDA) and an Empower software for data 
processing. Chromatographic separation was carried out 
in a Kromasil C18 column (150 x 4,6 mm i.d.; particle 
size, 5,0 µm) guarded by a pre-column filter in-line 
Ultra (Phenomenex, USA). The mobile phase was 
composed of water (A) and acetonitrile (B), acidified 
with 0.01 e 0.08% trifluoracetic acid (v/v), respectively, 
filtered through a 0.45 μm porous nylon membrane and 
degassed in ultrasonic bath for 30 minutes. The gradient 
profile was adjusted as follows: 0.00 min. 5% eluent B, 
15.00 minutes eluent 100% B. After isocratic elution 
was carried out up to 20.00 min eluent 100% B. 
Between the injections a 10 min equilibrium was 
performed using 5% B eluent. Sample were injected 
with auto-sampler in a volume of 10 µL. Eluent system 
was pumped at a flow rate of 0.7 mL/min and detection 
wavelength was set to 210 nm. 
 
Method Validation 
 
System Suitability 
 
Tests were performed to verify the adequacy of the 
chromatographic system for the analysis. During 
validation, peak area parameters, retention time and 
number of plates, referring to the peak atropine 
standard, were analyzed and evaluated by the relative 
standard deviation of the measurements on the different 
validation days. 
 
Specificity/Selectivity 
 
The data were obtained by comparing the ultraviolet 
profile and the purity of the atropine peak from the 
injection of the standard atropine solution (125 μg/mL) 
and the sample solution and analyzing the areas of 
atropine in solution of the sample with and without 
addition of standard atropine. 
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Linearity and Limits of Detection and Quantification 
(LOD e LOQ) 
 
Performed by injecting different dilutions of a stock 
solution of atropine standard (500 μg/mL). Three curves 
of the reference substance were constructed on different 
days with 7 points (injected in triplicate), corresponding 
to a concentration range of atropine between 50 and 200 
μg/mL. The linearity of the method was verified from 
the measurement of the area of the peak referring to the 
chemical marker in the chromatogram. The regression 
coefficient was evaluated and the statistical treatment 
was performed using the least squares method and 
analysis of variance. 
LOD and LOQ were calculated from the data 
obtained in the linearity study and through Equations: 
LOD = (3.3 x s) / I and LOQ = (10 x s) / I, at were, s = 
Mean standard deviation of the intercept of the three 
curves and I = Average slope of the three curves. 
 
Precision 
 
Repeatability (intra-days) was performed by 
analyzing six extracts from the sample, injected in 
triplicate in HPLC. 
Intermediate precision (inter-days) was performed 
by analyzing, on three different days, three extracts 
were prepared and injected in triplicate on HPLC. 
Interlaboratory reproducibility was performed in 
collaboration with the pharmacognosy laboratories of 
the Federal Universities of Paraná (UFPR) and of 
Pernambuco (UFPE). The sample and standard atropine 
were sent for analysis along with protocol describing the 
methodology. The analyzis were performed in triplicate 
and the results found were compared and the DPR was 
calculated among the means of the determinations in the 
different laboratories. Atropine levels and the relative 
standard deviation (RSD) of the means were evaluated. 
 
Accuracy 
 
Standard atropine solution at concentrations of 80, 
100 and 120% (relative to the extraction of plant 
material) was added at the final stage of the extraction 
process. The levels recovered from atropine and RSD of 
the means was evaluated. 
 
Robustness 
 
Performed by modifying previously established 
parameters of analysis. The atropine levels were 
calculated and the RSD and relation to the normal 
condition analysis was evaluated. The modified 
parameters were: mobile phase flow (± 0,05 mL/min); 
Wavelenght (± 5 nm) and column supplier (Nano 
Separation Technologies - NST). 
 
 
 
 
Analysis of Commercial Samples 
 
Samples Ab-01, Ab-02, Ab-03 and Ab-04 were 
prepared as described in item 2.2 and analyzed in the 
developed and validated method. 
 
Results 
 
Method Development 
 
In the development of the method, the standard and 
sample solutions produced the chromatograms shown in 
Figure 2, were it is possible to identify the atropine peak 
at the retention time of approximately 7.7 minutes.  
 
 
 
Figure 2 Overlay chromatogram of the atropine sample and 
standard solutions. 
 
Method Validation 
 
System Suitability 
 
The routine analysis of the atropine standard was 
achieved under the conditions of the method developed 
by HPLC. The parameter values and their relative 
standard deviation (RSD%) are shown in Table 1. In 
summary, the results for each parameter demonstrated 
that the system is suitable for atropine analysis.   
 
Table 1 Results of system suitability for atropine 
quantification method in A. belladonna leaves. 
Compound Parameter Mean RSD (%) 
Atropine 
Retention Time 
(min) 
7.691 0.8008 
Number of plates 
(N) 
15231.2 3.523 
Peak Area (mV.s) 
1971669 1.114 
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Specificity / Selectivity 
 
The specificity/selectivity was evidenced with UV 
profiles of the atropine peak in similar reference and 
sample solutions, as well as the observation of the peak 
purity shown in Figure 3 (a and b). The selectivity was 
confirmed by the addition of a reference substance in 
the sample solution, which produced an increase only in 
the peak area of the sample, without changing the area 
of the adjacent peaks (Figure 3c). The areas measured 
before and after standard addition were 892459 and 
1964117 for the atropine peak and there was no change 
in the other areas of the chromatogram. It was possible 
through the tests to observe that the method is specific 
and selective for analysis of the metabolite under study  
 
 
 
 
Figure 3 (A) UV profile of the atropine sample solution and 
the standard; (B) Peak purity of atropine sample solution; (C) 
Overlay chromatogram of the atropine sample solution with 
and without addition of atropine standard. 
 
Linearity, LOD and LOQ 
 
Was determined of reference solutions with 
concentrations range 50-200 µg/mL, with regression 
equation Y = 15490x + 18019 and r2 = 0.9996. LOD and 
LOQ were 3.75 and 11.3 µg/ml, respectively. The 
values obtained in the analysis of variance (ANOVA) 
show that there are significant differences between the 
different concentrations and respective areas (P-value 
<0.05 and F> Fcritic), with a confidence interval of 95% 
(α = 0.05). 
 
Precision 
 
The method proved to be precise, with mean 
atropine levels of 0.267% and RSD equal to 2.78% for 
repeatability and intermediate steps. The results of 
Interlaboratory Reproducibility were also satisfactory, 
since the mean amount between laboratories was equal 
to 0.262% with RSD of 1.38%. Table 2 presents the 
results of this validation step. 
 
 
 
 
 
Table 2 Results the precision step for atropine quantification 
method in A. belladonna leaves. 
Precision 
Intra-days Inter-days 
Replicat
e 
% 
Atropin
e 
Replicat
e 
% 
Atropine 
Day 1 
% 
Atropin
e Day 2 
% 
Atropin
e Day 3 
1 0.2651 1 0.2725 0.2681 0.2522 
2 0.2505 2 0.2760 0.2661 0.2527 
3 0.2803 3 0.2733 0.2638 0.2631 
4 0.2754 Mean 0.2739 0.2660 0.2560 
5 0.2685 RSD (%) 0.6666 0.8215 2.401 
6 0.2620 
Mean: 0.2657     RSD (%): 2.776 Mean 0.2670 
RSD (%) 3.922 
Reproducibility Interlaboratorial 
Replicate 
% 
Atropine 
UFRGS 
% Atropine 
UFPR 
% 
Atropine 
UFPE 
 
1 0.2453 0.2602 0.2681 
 
2 0.2673 0.2595 0.2662  
3 0.2655 0.2606 0.2638  
Mean 0.2594 0.2601 0.2660  
RSD (%) 4.718 0.2000 0.8215  
Mean: 0.2618 %                RSD (%): 1.34 %  
 
 
Accuracy 
 
The recovered levels of atropine standard are shown 
in table 3. The mean recovery of method was 103.0% 
with RSD of less than 5%, according to the official 
guidelines. In this way, developed method can be 
considered accurate. 
 
Table 3 Results the recovery study to evaluate accuracy for 
atropine quantification method in A. belladonna leaves. 
Solution 
Standard 
Added 
(µg/mL) 
Experimental 
Concentration 
(µg/mL) 
Average Recovery 
(%) 
SS* - 56.02 - 
ASS* 55.10 - - 
RS80* 44.08 100.7 101.4 
RS100* 55.10 112.9 103.3 
RS120* 66.12 125.0 104.4 
  
Mean 103.0 
  
RSD (%) 1.484 
*SS – Sample Solution; ASS – Atropine Standard Solution; 
RS80,100,120 – Recoverys Solutions 80, 100, 120 % 
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Robustness 
 
The method was robust, considering that no altered 
parameter produced a RSD result higher than 5% in 
relation to the mean atropine content of the analyzes 
under normal conditions. Table 4 shows the results 
obtained in the method validation step. 
 
Table 4 Results of robustness step for atropine quantification 
method in A. belladonna leaves. 
Variation Atropine (%) RSD (%)* 
Mobile phase flow (0.65 
mL/min) 
0.2641 3.123 
Mobile phase flow (0.75 
mL/min) 
0.2531 0.1125 
Wavelength (λ = 205 nm) 0.2516 0.3123 
Wavelength (λ = 215 nm) 0.2498 0.7992 
Colunm supplier (NST) 0.2564 1.020 
*RSD calculated relative to the normal analysis condition 
 
Analysis of Commercial Samples 
Analysis of commercial samples revealed 
levels varying from 0.16 to 0.27% of atropine (Table 5), 
indicating marked variability between the different 
samples. 
 
Table 5 Analysis result of atropine content in commercially 
obtained samples. 
Replicate Ab-01 
(% 
atropine) 
Ab-02 
(% 
atropine) 
Ab-03 
(% 
atropine) 
Ab-04 
(% atropine) 
1 0.2681 0.2051 0.1556 0.2769 
2 0.2662 0.2100 0.1570 0.2705 
3 0.2638 0.1931 0.1686 0.2702 
Mean 0.2660 0.2027 0.1604 0.2726 
RSD (%) 0.8215 4.2973 4.4572 1.3918 
 
Conclusion 
Considering the reports of determination of this type 
of secondary metabolite, using HPLC, in different plant 
materials, it was possible to obtain a method 
successfully developed for this purpose. The developed 
method was validated, showing precision, accuracy and 
robustness, with all the steps presenting RSD results 
below 5%.  
A. belladonna is a plant material widely used in 
therapeutics and, since official quantification methods 
involve titration techniques or gas chromatography, the 
method developed in this work is advantageous because 
it uses a technique that quantifies in a simple, fast and 
efficient way of the active in the plant drug, can be 
applied to the quality control routines, of the studied 
plant drug, with confidence. 
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